Fresenius Kabi's plant on Grand Island has a slogan: Saving lives one vial at a time. The plant, which employs about 800 people, makes sterile, injectable pharmaceuticals, used in doctors' offices ...
Fresenius SE's restructuring and dividend reinstatement signal strong growth. Read why FSNUF stock may not be a long-term buy ...
The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi. The biosimilar of IL-6 inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback